Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial

Evaluation of preclinical evidence prior to initiating early-phase clinical studies has typically been performed by selecting individual studies in a non-systematic process that may introduce bias. Thus, in preparation for a first-in-human trial of mesenchymal stromal cells (MSCs) for septic shock,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:eLife
Asıl Yazarlar: Lalu, Manoj M, Sullivan, Katrina J, Mei, Shirley HJ, Moher, David, Straus, Alexander, Fergusson, Dean A, Stewart, Duncan J, Jazi, Mazen, MacLeod, Malcolm, Winston, Brent, Marshall, John, Hutton, Brian, Walley, Keith R, McIntyre, Lauralyn
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: eLife Sciences Publications, Ltd 2016
Konular:
Epidemiology and Global Health
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153252/
https://ncbi.nlm.nih.gov/pubmed/27870924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.17850
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller